Zoledronic acid - PDFSEARCH.IO - Document Search Engine

Zoledronic acid
Results: 198

#	Item
91	PRODUCT MONOGRAPH XGEVA Pr Add to Reading List Source URL: www.amgen.ca Language: English - Date: 2014-10-10 12:55:23 Amgen Denosumab Zoledronic acid Osteoporosis Osteonecrosis of the jaw Multiple myeloma Osteoprotegerin Adverse effect Alendronic acid Medicine Health Bisphosphonates
92	Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tu Add to Reading List Source URL: www.kidneycancercanada.ca Language: English - Date: 2012-11-27 15:44:03 Imidazoles Zoledronic acid Multiple myeloma Prostate cancer Placebo Denosumab Medicine Health Bisphosphonates
93	u) NOVARTIS ONCOLOGY wmrtic cNiarmauuti Oncol&y 5MedicaCfJairs Add to Reading List Source URL: www.fda.gov Language: English - Date: 2002-12-12 08:11:04 Eli Lilly and Company Zoledronic acid Acetic acid Methadone Chemistry Ketones Novartis
94	Program # Abstract Title 2011 SABCS Disclosure Report F. Name M. Name L. Name Add to Reading List Source URL: www.sabcs.org Language: English - Date: 2012-02-27 11:38:46 Ribbon symbolism Cancer treatments Trastuzumab Zoledronic acid Breast cancer Lapatinib Denosumab HER2/neu Adjuvant therapy Chemistry Organic chemistry Medicine
95	“An international scientific symposium for interaction and exchange among basic scientists and clinicians in breast cancer.” Newsletter 2 D -,  Add to Reading List Source URL: www.sabcs.org Language: English - Date: 2011-12-08 12:25:55 Ribbon symbolism AstraZeneca Aromatase inhibitors Organofluorides Sulfones Zoledronic acid Breast cancer treatment Trastuzumab Breast cancer Chemistry Medicine Organic chemistry
96	Summer[removed]Bone Builders Volunteer Newsletter World’s Largest Osteoporosis Congress Closes; Significant Studies Released Toronto, Canada – June 6, 2006 [Press Release by the International Osteoporosis Foundation] Add to Reading List Source URL: cals.arizona.edu Language: English - Date: 2010-02-22 12:40:32 Aging-associated diseases Bisphosphonates Osteoporosis Geriatrics Bisphosphonate Alendronic acid Zoledronic acid Sarcopenia Bone density Medicine Health Osteopathies
97	PDF Document Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-05-20 11:17:26 Clinical research Term of patent in the United States Zoledronic acid Pharmaceutical industry Novartis Term of patent Food and Drug Administration Pharmaceutical sciences United States patent law Patent law
98	DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug AdminiMration Rockville MD 20867 Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-05-20 11:17:26 Pharmaceutical sciences Health Pharmaceutical industry Pharmacology Clinical research New Drug Application Term of patent in the United States Investigational New Drug Zoledronic acid Food and Drug Administration Medicine Drug safety
99 $Calcium / Osteopathies / Bisphosphonates / Osteoporosis / Vitamin D / Hypercalcaemia / Zoledronic acid / Bone fracture / Atenolol / Medicine / Health / Chemistry$	MEDICATION GUIDE Reclast® (RE-clast) (zoledronic acid) Injection Read the Medication Guide that comes with Reclast before you start taking it and each time you get a refill. There may be new information. This Medication Add to Reading List Source URL: www.pharma.us.novartis.com Language: English - Date: 2014-07-11 06:14:27 Calcium Osteopathies Bisphosphonates Osteoporosis Vitamin D Hypercalcaemia Zoledronic acid Bone fracture Atenolol Medicine Health Chemistry
100	U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may Add to Reading List Source URL: www.fda.gov Language: English Health Endocrinology Ribbon symbolism Osteoporosis Prostate cancer Aromatase inhibitor Menopause Breast cancer Zoledronic acid Medicine Amgen Denosumab

UPDATE